ABI-231 is a potent, orally bioavailable tubulin inhibitor that interacts with the colchicine binding site and is currently undergoing clinical trials for prostate cancer. ABI-231, has an average IC50 = 5.2 nM against panels of melanoma and prostate canc
Molekulargewicht:
413.85
CAS Nummer:
[2635953-17-0]
Formel:
C21H20ClN3O4
Target-Kategorie:
Others
T69557
T69557
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten